Aytu Biopharma (AYTU) Cash from Investing Activities (QoQ) (2015 - 2025)
Aytu Biopharma (AYTU) Cash from Investing Activities (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 21.45 Mn | -5.27 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -4,272.46% |
| Mar 31, 2025 | -147.59% |
| Dec 31, 2024 | -61.94% |
| Sep 30, 2024 | 1,220.59% |
| Jun 30, 2024 | 24.44% |
| Mar 31, 2024 | 74.14% |
| Dec 31, 2023 | -128.95% |
| Sep 30, 2023 | 50.97% |
| Jun 30, 2023 | -15,600.00% |
| Mar 31, 2023 | 120.00% |
| Dec 31, 2022 | -111.90% |
| Sep 30, 2022 | 202.44% |
| Jun 30, 2022 | 41.43% |
| Mar 31, 2022 | 97.71% |
| Dec 31, 2021 | -3,447.67% |
| Sep 30, 2021 | 96.46% |
| Dec 31, 2020 | -233.33% |
| Sep 30, 2020 | 80.12% |
| Jun 30, 2020 | -113.16% |
| Mar 31, 2020 | 107.00% |